The Comparison of Sympathetic Blockade of Stellate Ganglion Block and Thoracic Sympathetic Ganglion Block

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

118 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-07-10

Study Completion Date

2026-01-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

For patients scheduled to undergo upper limb sympathetic nerve block due to chronic neuropathic pain in the upper limb lasting more than 3 months, the ultrasound-guided stellate ganglion block group (S group) and the fluoroscopy-guided thoracic sympathetic nerve block group (T) Patients are randomly assigned 1:1 to one of the groups, and the procedure is performed. To evaluate the effectiveness of sympathetic nerve blockade, temperature changes in both palms are measured twice, 20 minutes before and 20 minutes after the procedure, using an infrared thermographer. Other variables related to the procedure are surveyed by outpatient visit or telephone before the procedure, after the procedure, before returning home, and 1 week and 1 month after the procedure.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Comparison of Sympathetic Blockade of Stellate Ganglion Block and Thoracic Paravertebral Block

NCT04876989

Complex Regional Pain Syndromes Postherpetic Neuralgia Phantom Limb Pain +3 more

COMPLETED NA

Comparison of the Efficacy of the Ultrasound With Fluoroscopy in Guidance of Lumbar Sympathetic Block

NCT02737527

Complex Regional Pain Syndrome Postherpetic Neuralgia Diabetic Polyneuropathy +1 more

UNKNOWN NA

Impact of Local Anesthetic Volume During Ultrasound-guided Stellate Ganglion Block

NCT03401801

Neuropathic Pain

COMPLETED NA

The Success of Lumbar Sympathetic Ganglion Block Using Lower Extremity Perfusion Index

NCT06241820

Chronic Pain Complex Regional Pain Syndromes Peripheral Neuropathy +1 more

COMPLETED NA

Sensorimotor Block Dynamics and Hemidiaphragmatic Palsy: Selective Trunk Block vs Supraclavicular Brachial Plexus Block

NCT05649644

Musculoskeletal Diseases or Conditions

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients aged 19 to 85 with upper limb pain are directly informed about the study, recruited, and enrolled at the Seoul National University Hospital Pain Center.

Before and after the procedure, continuous monitoring of electrocardiography, blood pressure, pulse rate, and oxygen saturation is carried out.

Before undergoing thoracic sympathetic ganglion block (TSGB) guided by fluoroscopy or ultrasound-guided stellate ganglion block (SGB), the temperature of both palms is measured using an infrared thermometer. Prior to the procedure, Doppler mode ultrasound equipment is used to measure blood flow velocity in the upper limb arteries (brachial artery).

In the case of ultrasound-guided stellate ganglion block, the patient is placed in a supine position, and the procedure is performed using ultrasound guidance to inject 5 mL of 1% mepivacaine at the level of C6. For fluoroscopy-guided thoracic sympathetic ganglion block, the patient is positioned prone, and 3 mL of 1% mepivacaine is injected at the level of T3. In both cases, the procedure is performed by a specialist with a rank of professor or higher who specializes in pain management.

After the procedure, the palm temperature is measured again 20 minutes later using an infrared thermometer.

Blood flow velocity in the upper limb arteries (brachial artery) is also measured 20 minutes post-procedure using Doppler mode ultrasound equipment.

Additionally, various procedure-related variables are assessed through outpatient visits or telephone surveys conducted before the procedure, at discharge, one week post-procedure, and four weeks post-procedure.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Pain Neuropathic Pain Complex Regional Pain Syndromes Post Herpetic Neuralgia Post Laminectomy Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Ultrasound-guided stellate ganglion block (US-guided SGB)

In the case of ultrasound-guided stellate ganglion block, the patient is made to lie down and stellate ganglion block is performed by injecting 5 mL of 1% mepivacaine at the level of the 6th cervical vertebra using ultrasound.

Group Type ACTIVE_COMPARATOR

Ultrasound

Intervention Type DEVICE

Ultrasound-guided stellate ganglion block with 1% mepivacaine 5 mL

Fluoroscopy-guided thoracic sympathetic ganglion block (FS-guided TSGB)

In the case of fluoroscopic device-guided thoracic sympathetic nerve block, place the patient prone and inject 3 mL of 1% mepivacaine at the level of the third thoracic vertebra to perform thoracic sympathetic nerve block.

Group Type ACTIVE_COMPARATOR

Fluoroscopy

Intervention Type DEVICE

Fluoroscopic-guided thoracic sympathetic ganglion block with 1% mepivacaine 3 mL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ultrasound

Ultrasound-guided stellate ganglion block with 1% mepivacaine 5 mL

Intervention Type DEVICE

Fluoroscopy

Fluoroscopic-guided thoracic sympathetic ganglion block with 1% mepivacaine 3 mL

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients with 19 - 85 years
* Patients with chronic upper extremity pain that lasts for more than 3 months
* Neuropathic pain conditions such as postherpetic neuralgia, complex regional pain syndrome, post laminectomy syndrome of cervical spine
* Patients judged to require sympathetic blockade by pain physician

Exclusion Criteria

* Patient refusal
* Presence of upper limb vascular disorders
* History of previous thoracic sympathetic ganglion removal or neurolysis
* Abnormal findings in blood coagulation tests
* Systemic infection or local injection site infection
* Anatomical deformities at the injection site
* Allergic reactions to the injected medications
* Higher baseline hand temperature on the procedure side than the tympanic temperature (36.5°C) on pre-procedure thermography
* Other cases deemed inappropriate by the investigator

Minimum Eligible Age

19 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No